The Efficacy of Beneficial Intestinal Microbiota in the Treatment of Migraine and Its Mechanism: Basic and Clinical Studies
NCT ID: NCT07092241
Last Updated: 2025-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2023-01-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tryptophan Metabolites in Pediatric Migraine
NCT05969990
Probiotics for the Prophylaxis of Migraine
NCT04305522
Migraine in Adolescents
NCT05654012
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches
NCT04211454
Association of Helicobacter Pylori Infection and Migraine
NCT06558578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The placebo group
Double set parallel
microbiota
Bifidobacterium breve and Bifidobacterium longum
microbiota
Bifidobacterium and Lactobacillus
treated group
microbiota
Bifidobacterium breve and Bifidobacterium longum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
microbiota
Bifidobacterium breve and Bifidobacterium longum
microbiota
Bifidobacterium and Lactobacillus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Receiving probiotic treatment for the past one month
3. Multiple congenital anomalies, for instance, meningoencephalocele, chromosomal anomalies, and congenital intestinal atresia, etc.
4. Mental retardation that is difficult to describe the symptoms
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202207086RIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.